Humber River Hospital is a major acute care hospital in Toronto, Ontario, Canada, located in the northwest part of Toronto, near Highway 401 and Keele Street.

There are 722 beds in Humber River Hospital.

During the past decade, Humber River Hospital conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 14 clinical trials were completed, i.e. on average, 45.2% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 9 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Humber River Hospital" #1 sponsor was "NCIC Clinical Trials Group" with 16 trials, followed by "Canadian Cancer Trials Group" with 4 trials sponsored, "Celgene" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "Ottawa Hospital Research Institute" with 4 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Humber River Hospital" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 3 trials as a collaborator, "Eastern Cooperative Oncology Group" with 3 trials as a collaborator, "Humber River Hospital" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "National Cancer Institute (NCI)" with 3 trials as a collaborator. Other collaborators include 83 different institutions and companies that were collaborators in the rest 83 trials.

According to Clinical.Site data, the most researched conditions in "Humber River Hospital" are "Breast Cancer" (8 trials), "Colorectal Cancer" (3 trials), "Covid19" (3 trials), "Lymphoma" (3 trials) and "Obesity" (3 trials). Many other conditions were trialed in "Humber River Hospital" in a lesser frequency.

Most popular intervention types in "Humber River Hospital" are "Drug" (48 trials), "Other" (14 trials), "Biological" (5 trials), "Device" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "prednisone" (4 trials), "Capecitabine" (3 trials), "Cyclophosphamide" (3 trials) and "Rituximab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Humber River Hospital" are 56 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Humber River Hospital". 1 are not yet recruiting, 6 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 40 completed trials in Humber River Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Humber River Hospital, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 12 trials that are defined as “Not Applicable".